Please login to the form below

Not currently logged in
Email:
Password:

clinical benefit

This page shows the latest clinical benefit news and features for those working in and with pharma, biotech and healthcare.

New industry standards group launched

New industry standards group launched

New industry standards group launched. Align Clinical CRO will improve clinical trial collaboration. ... Henry Levy, president of Align Clinical CRO, said: “There’s tremendous potential to enhance clinical trial execution through common technology

Latest news

More from news
Approximately 1 fully matching, plus 147 partially matching documents found.

Latest Intelligence

  • Patient recruitment and engagement standards Patient recruitment and engagement standards

    And the reality: 50% of clinical research sites don’t recruit a single patient. ... A number of studies have revealed that awareness changes patients’perceptions about clinical trials, enrolment and the risk/benefit ratio of getting involved.

  • Taking a lean and careful approach Taking a lean and careful approach

    Chemotherapy and Pharmacology, which concluded its treatment regimen showed ‘encouraging clinical benefit’. ... Clinical trials. The company is moving cautiously and set its clinical trials in Israel, Italy, Turkey and Greece.

  • Strengthening market access deliverables by harnessing the patient journey Strengthening market access deliverables by harnessing the patient journey

    Topics such as the clinical value of new products, or what impact the product has on outcomes are relevant to multiple stakeholders. ... management, clinical benefit and economic/humanistic benefit.

  • The value of early asset development and commercialisation The value of early asset development and commercialisation

    Linking the clinical benefit of a product to a real-world benefit that markets care about, insurers will pay for and that will improve patients’ lives is critical for pipeline assets ... It will follow the asset development journey, defining value from

  • Reaching new heights Reaching new heights

    Developed markets will continue to account for the majority of medicine spending due both to higher prices per unit and the mix of newer medicines that bring meaningful clinical benefit to

More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest appointments

  • Dr Irina Antonijevic joins vasopharm Dr Irina Antonijevic joins vasopharm

    In this role, Dr Antonijevic will be responsible for advancing the clinical development of the cerebrovascular specialist's lead orphan drug candidate, VAS203. ... Not only will we benefit from her clinical capabilities in our ongoing pivotal study of

  • ICON's CEO named chair of ACRO ICON's CEO named chair of ACRO

    ICON's CEO named chair of ACRO. Trade body for clinical research organisation elects Ciaran Murray. ... I look forward to continuing the work that ACRO has done in promoting our industry as one that conducts safe, ethical and high-quality clinical

  • Industry veteran Louis Nisbet joins Sygnature board Industry veteran Louis Nisbet joins Sygnature board

    The UK-based clinical research organisation (CRO) will benefit from Dr Nisbet's extensive experience in the life sciences industry, which includes spells in research at Roche, Glaxo and SmithKline.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Why and how doctors should be involved in startups

    provide useful clinical insight that can benefit a startup.

  • Immunotherapy in oncology

    These three states align with the clinical observations of response, stable disease and progression of disease. ... However, the group recognised that delayed responses and prolonged stable disease were having a significant survival benefit, underscoring

  • How will the NHS’s new medicines savings drive affect pharma?

    Engagement tactics must balance clinicians’ demand for products that show strong clinical benefit and patient safety against medicines management teams’ focus on the cost savings that can be generated by specific ... full benefit of expensive drugs,

  • The Heart of the Matter 7: Reality Dawns

    In tandem, as the limitations of the 'gold standard' randomised clinical trial (RCT) data are increasingly exposed, European initiatives such as the Innovative Medicines Initiative GetReal and ADAPT-SMART underline how ... The Centre has four areas of

  • What will the NHS’s Capped Expenditure Process (CEP) mean for pharma?

    Balancing doctors’ demands for drugs that demonstrate strong clinical benefit and patient safety against medicines management teams’ focus on cost savings will be critical in CEP areas. ... In such areas, bringing together multi-disciplinary networks

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics